149,584 Shares in DaVita Inc. $DVA Acquired by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. purchased a new stake in DaVita Inc. (NYSE:DVA) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 149,584 shares of the company’s stock, valued at approximately $19,875,000. Rakuten Investment Management Inc. owned approximately 0.21% of DaVita as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently made changes to their positions in the stock. NewEdge Advisors LLC lifted its position in DaVita by 20.8% in the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after acquiring an additional 88 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of DaVita by 19.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 179,140 shares of the company’s stock valued at $27,403,000 after purchasing an additional 28,739 shares during the period. Martin Capital Advisors LLP lifted its holdings in shares of DaVita by 4.7% in the second quarter. Martin Capital Advisors LLP now owns 8,924 shares of the company’s stock valued at $1,271,000 after purchasing an additional 400 shares in the last quarter. V Square Quantitative Management LLC boosted its position in shares of DaVita by 22.8% during the second quarter. V Square Quantitative Management LLC now owns 2,422 shares of the company’s stock worth $345,000 after buying an additional 449 shares during the period. Finally, Truist Financial Corp grew its holdings in shares of DaVita by 1.9% during the second quarter. Truist Financial Corp now owns 8,646 shares of the company’s stock worth $1,232,000 after buying an additional 163 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on DVA. Weiss Ratings reaffirmed a “hold (c)” rating on shares of DaVita in a research report on Monday, December 29th. Cowen reissued a “hold” rating on shares of DaVita in a research report on Monday, November 3rd. Zacks Research raised shares of DaVita from a “strong sell” rating to a “hold” rating in a research report on Friday, November 28th. TD Cowen lowered their price target on shares of DaVita from $154.00 to $133.00 and set a “hold” rating on the stock in a research note on Monday, November 3rd. Finally, Truist Financial reduced their price objective on shares of DaVita from $140.00 to $128.00 and set a “hold” rating for the company in a research note on Monday, January 5th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus target price of $145.60.

DaVita Trading Down 0.8%

Shares of DVA opened at $103.95 on Wednesday. The company’s fifty day simple moving average is $115.46 and its 200 day simple moving average is $127.06. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $179.60. The company has a market cap of $7.34 billion, a price-to-earnings ratio of 10.71, a PEG ratio of 0.64 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $2.51 EPS for the quarter, missing analysts’ consensus estimates of $3.17 by ($0.66). The firm had revenue of $3.42 billion during the quarter, compared to the consensus estimate of $3.43 billion. DaVita had a net margin of 5.80% and a negative return on equity of 13,370.89%. The business’s revenue was up 4.8% on a year-over-year basis. During the same period last year, the business earned $2.59 EPS. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. As a group, research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.